Tao Jiang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma (NCT05552651) | Tao Jiang | 2022-09-20 |
Track Tao Jiang automatically
Every clearance here is in the API, with alerts when new ones post.